Novo Nordisk's pricing approaches within the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of price gouging, mentioning the stark contrast involving U.S. costs and those in Europe and copyright.Novo Nordisk A/S is really a Danish multinational pharmaceutical company headquartered in Bagsværd,[3]